No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Bortezomib / administration & dosage*
-
Bortezomib / adverse effects
-
Humans
-
Induction Chemotherapy / adverse effects
-
Induction Chemotherapy / methods
-
Multiple Myeloma / complications
-
Multiple Myeloma / drug therapy*
-
Peripheral Nervous System Diseases / chemically induced*
-
Risk Factors
Substances
-
Antineoplastic Agents
-
Bortezomib